Multi-omics analysis of distinct hybrid epithelial/mesenchymal states in ovarian carcinosarcoma infers functional diversity and therapeutic vulnerabilities

Abstract Ovarian carcinosarcoma (OCS) is a rare and aggressive malignancy characterised by epithelial (carcinomatous) and mesenchymal (sarcomatous) components. This biphasic nature arises through epithelial-to-mesenchymal transition (EMT), which is a continuum involving transient and reversible states intermediate between full epithelial and mesenchymal extremes. Hybrid epithelial/mesenchymal (E/M) cell states display elevated epithelial-to-mesenchymal plasticity, and are likely drivers of tumour initiation, metastasis, immune evasion, and drug resistance in many cancer types. Therapeutic targeting of highly drug-resistant mesenchymal cells has resulted in discordant outcomes, potentially due to the enrichment of these remarkably plastic and aggressive partial EMT (p-EMT) states, which may represent promising targets for novel therapies. Using single-nucleus RNA sequencing and spatial transcriptomics, we characterised an extensive cohort of OCS patient-derived xenograft models to elucidate genes and signalling pathways associated with hybrid E/M cell states. We demonstrated that genes implicated in DNA replication and repair, cell cycle progression, and neurotransmitter signalling were over-represented in intermediate EMT cell states, underpinning their enhanced proliferative and dynamic nature. These p-EMT states were also enriched for genes involved in multiple signal transduction pathways previously implicated in EMP, including MAPK and Wnt signalling. As EMT regulation in cancer is complex and multi-layered, we used flow cytometry and cell surface proteomics to identify surface proteins associated with p-EMT states in OCS, including DPP4 as a prominent candidate for therapeutic targeting, alongside B7-H4/VTCN1, MUC15, and GGT1. We highlight novel therapeutic approaches for individuals with OCS and, potentially, other highly aggressive and drug-resistant cancers, where EMT is a key feature.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-16
DOI
https://doi.org/10.21203/rs.3.rs-11545684/v1
Primary Topic
Cancer Cells and Metastasis
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Multi-omics analysis of distinct hybrid epithelial/mesenchymal states in ovarian carcinosarcoma infers functional diversity and therapeutic vulnerabilities

Cassandra J. Vandenberg, Daniela Amann‐Zalcenstein, Andrew Farrell, Anthony Hadla et al.
Research Square
Cancer Cells and Metastasis
preprint

Multi-omics analysis of distinct hybrid epithelial/mesenchymal states in ovarian carcinosarcoma infers functional diversity and therapeutic vulnerabilities

Cassandra J. Vandenberg, Daniela Amann‐Zalcenstein, Andrew Farrell, Anthony Hadla, Ling Ling, Holly E. Barker, Casey J. A. Anttila, Xueyi Dong, Gayanie Ratnayake, Yunshun Chen, Rory J. Bowden, Jumana M. Yousef, Clare L. Scott, Vineet Vaibhav, Ruvimbo D Mishi, Jiayu Wang, Laura Gianni
preprint en

Abstract

Abstract Ovarian carcinosarcoma (OCS) is a rare and aggressive malignancy characterised by epithelial (carcinomatous) and mesenchymal (sarcomatous) components. This biphasic nature arises through epithelial-to-mesenchymal transition (EMT), which is a continuum involving transient and reversible states intermediate between full epithelial and mesenchymal extremes. Hybrid epithelial/mesenchymal (E/M) cell states display elevated epithelial-to-mesenchymal plasticity, and are likely drivers of tumour initiation, metastasis, immune evasion, and drug resistance in many cancer types. Therapeutic targeting of highly drug-resistant mesenchymal cells has resulted in discordant outcomes, potentially due to the enrichment of these remarkably plastic and aggressive partial EMT (p-EMT) states, which may represent promising targets for novel therapies. Using single-nucleus RNA sequencing and spatial transcriptomics, we characterised an extensive cohort of OCS patient-derived xenograft models to elucidate genes and signalling pathways associated with hybrid E/M cell states. We demonstrated that genes implicated in DNA replication and repair, cell cycle progression, and neurotransmitter signalling were over-represented in intermediate EMT cell states, underpinning their enhanced proliferative and dynamic nature. These p-EMT states were also enriched for genes involved in multiple signal transduction pathways previously implicated in EMP, including MAPK and Wnt signalling. As EMT regulation in cancer is complex and multi-layered, we used flow cytometry and cell surface proteomics to identify surface proteins associated with p-EMT states in OCS, including DPP4 as a prominent candidate for therapeutic targeting, alongside B7-H4/VTCN1, MUC15, and GGT1. We highlight novel therapeutic approaches for individuals with OCS and, potentially, other highly aggressive and drug-resistant cancers, where EMT is a key feature.

Research Square
Royal Women's Hospital (AU), Walter and Eliza Hall Institute of Medical Research (AU)
Cancer Cells and Metastasis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon